pharmaceutical

Trump Gives Companies 60 Days to Slash Drug Prices

President Trump sent letters to seventeen drug manufacturers, listing steps that must be taken to reduce prescription drug prices.

Major Pharmaceutical Company Investing in U.S.

Pharmaceutical company AstraZeneca committed to investing $50 billion in the United States by 2030.

Biogen’s $2 Billion Bet on North Carolina Biotech

Biogen has announced a $2 billion investment to upgrade and expand its North Carolina operations, emphasizing automation and artificial intelligence in its manufacturing capabilities. The move solidifies its role as the largest biotechnology employer in the state and positions the company for future pharmaceutical innovation.

Trump Signs Order Slashing Drug Prices

President Donald Trump signed an executive order on Monday directing drug prices to be cut by an estimated 59%.

Trump Expected to Impose Tariffs on Pharmaceuticals

President Donald Trump warned that tariffs are to be imposed on non-U.S.-based pharmaceuticals.

Drugmaker to Invest Billions in New U.S. Manufacturing Plants

Drugmaker Eli Lilly announced plans to invest $27 billion in manufacturing plants in the United States.

Latest news

- Advertisement -spot_img